Background-Paclitaxel can inhibit vascular smooth muscle proliferation in vitro, and early studies suggest that paclitaxel may be useful in preventing restenosis.
Background-Three-month studies of stent-delivered brachytherapy in the rabbit model show reduced neointimal growth.However, intimal healing is delayed, raising the possibility that intimal inhibition is merely delayed rather than prevented. The purpose of this study was to explore the long-term histological changes after placement of -emitting radioactive stents in normal rabbit iliac arteries. Methods and Results-Three-millimeter -emitting 32 P stents (6, 24, and 48 Ci) were placed in normal rabbit iliac arteries with nonradioactive stents as controls. Animals were euthanatized at 6 and 12 months, and histological assessment, morphometry, and analysis of endothelialization were performed. Morphometric measurements demonstrated a Ͼ50% reduction in intimal growth and percent lumen stenosis within 24-and 48-Ci stents versus control nonradioactive stents at both 6 and 12 months. However, the 24-and 48-Ci stents also showed delayed healing of the intimal surface, characterized by persistent fibrin thrombus with nonconfluent areas of matrix, incomplete endothelialization, and increased intimal cellular proliferation. Stent edge stenosis was present at 12 months in the 24-and 48-Ci stent groups, characterized by both intimal thickening and negative arterial remodeling. Conclusions-Inhibition of intimal growth is maintained 6 and 12 months after 32 P -emitting stent placement. However, delayed arterial healing, incomplete endothelialization, and edge effects are present.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.